The Diagnostic Imaging mammography modality focus page provides information, videos, podcasts, and the latest news about industry product developments, trial results, screening guidelines, and protocol guidance that touch on the use of mammography, including 2D digital mammography, digital breast tomosynthesis, and breast ultrasound.
November 12th 2024
Employing advanced deep learning convolutional neural networks, ProFound Detection Version 4.0 reportedly offers a 50 percent improvement in detecting cancer in dense breasts in comparison to the previous version of the software.
19th Annual New York Lung Cancers Symposium®
November 16, 2024
Register Now!
Medical Crossfire®: How Does Recent Evidence on PARP Inhibitors and Combinations Inform Treatment Planning for Prostate Cancer Now and In the Future?
View More
Medical Crossfire®: How Do the Experts Select and Sequence Therapies to Optimize Patient Outcomes and Quality of Life in Advanced Prostate Cancer?
View More
Lung Cancer Tumor Board®: Enhancing Multidisciplinary Communication to Optimize Immunotherapy in Stage I-III NSCLC
View More
Clinical Vignettes™: The Experts Explain How They Integrate PET Imaging into Metastatic HR+ Breast Cancer Care Settings
View More
School of Breast Oncology® Live Video Webcast: Clinical Updates from San Antonio
View More
Annual Hawaii Cancer Conference
January 25-26, 2025
Register Now!
21st Annual International Symposium on Melanoma and Other Cutaneous Malignancies®
February 8, 2025
View More
Community Practice Connections™: The 2nd Annual Hawaii Lung Cancers Conference®
View More
18th Annual New York GU Cancers Congress™
March 28-29, 2025
Register Now!
Clinical Case Vignette Series™: 41st Annual Miami Breast Cancer Conference®
View More
Medical Crossfire®: How Can Thoracic Teams Facilitate Optimized Care of Patients With Stage I-III EGFR Mutation-Positive NSCLC?
View More
Lung Cancer Tumor Board®: How Do Emerging Data for ICIs, BiTEs, ADCs, and Targeted Strategies Address Unmet Needs in the Therapeutic Continuum for SCLC?
View More
26th Annual International Lung Cancer Congress®
July 25-26, 2025
Register Now!
2025 International Symposium of Gastrointestinal Oncology (ISGIO)
September 12-13, 2025
Register Now!
Lung Cancer Tumor Board: Enhancing Precision Medicine in NSCLC Through Advancements in Molecular Testing and Optimal Therapy Selection
View More
(CME Credit Only) New Frontiers in Immunotherapy for SCLC: Insights From Latest Clinical Trials and Their Application in Real-World Treatment
View More
(MOC and CME Credit) New Frontiers in Immunotherapy for SCLC: Insights From Latest Clinical Trials and Their Application in Real-World Treatment
View More
(CME Credit Only) Lung Cancer Tumor Board®: The Pivotal Role of Multimodal Therapy in Leveraging Immunotherapy for Stage I-III NSCLC When the Goal Is Cure
View More
(MOC and CME Credit) Lung Cancer Tumor Board®: The Pivotal Role of Multimodal Therapy in Leveraging Immunotherapy for Stage I-III NSCLC When the Goal Is Cure
View More
Has mammography set itself up for a fall?
January 20th 2009One sure way to disappoint is to promise more than you can deliver. Mammography appears to be doing just that. A public survey conducted in Europe found that the vast majority of people hugely overestimate the life-saving benefits of breast and prostate cancer screening.
Uninsured minorities should gain from Obama-style healthcare reform
January 13th 2009A recent study suggests that by lowering access barriers to mammography, the Obama administration could help combat the tendency of uninsured minority women to delay seeking diagnosis for breast cancer. Delayed diagnosis translates into delayed treatment and a poorer prognosis for many women.
Digital mammography interpretation takes longer than film reading
January 9th 2009Researchers at the University of Texas M.D. Anderson Cancer Center in Houston have confirmed what mammographers have long suspected: Digital screening mammograms may take twice as long to read than film. Understanding all variables could boost or make up for interpretation speed.
Women at high risk for breast cancer benefit from both mammography, MRI
December 23rd 2008Alternating MRI with mammography every six months picks up breast cancers not identified by mammography alone for women at high risk, according to research out of the University of Texas M.D. Anderson Cancer Center in Houston.
Digital stereotaxy adds to GE digital mammo
December 4th 2008An add-on digital stereotaxy option for GE’s Senographe Essential lets users perform biopsies on its full-field digital mammography system, sparing institutions the expense of setting up a dedicated biopsy room, according to the company.
Automated breast ultrasound identifies nonexistent breast cancer lesions
December 3rd 2008Automated breast ultrasound should not replace handheld ultrasound in a diagnostic breast center but rather should be used in conjunction with it or play a role in screening breast ultrasound, according to a study presented at the 2008 RSNA meeting.
Strengths of tomosynthesis could hinder its adoption
December 3rd 2008While radiologists herald breast tomosynthesis as the hope for the future of breast imaging, several barriers hinder its widespread use. Its very ability to detect benign lesions dilutes the value of such detection, according to a keynote speech at the RSNA meeting.
Imaging analysts nail precise measurements for oncology research
December 3rd 2008Clinical trials in oncology demand standardized measurements of imaging scans to assess treatment response, but, unfortunately, the existing clinical workflow is not designed to produce these cohesive measurements on a routine basis. A group from Dana Farber Cancer Center has proposed using imaging analysts to deliver more consistent results.
Toshiba extends ultrasound reach in breast imaging
December 2nd 2008Toshiba America Medical Systems has positioned its MicroPure ultrasound technology as a way to better characterize microcalcifications. The new technology, showcased at RSNA 2008 on Toshiba’s Aplio XG ultrasound scanner, improves the detection of small calcifications that otherwise may evade detection with ultrasound.
Philips ultrasound upgrade targets breast imaging
November 30th 2008Enhancements in breast imaging mark the latest ultrasound upgrade from Philips Healthcare. Tissue aberration correction technology and algorithms built into the Vision 2009 upgrade for its iU22 radiological flagship are part of an integrated effort to better define tissue in fatty breasts, according to the company. An enabling technology is the Philips PureWave transducer and its coded beamformer, which have been present on earlier technologies.